Quizartinib (Ac220) in patients with flt3-Itd(+) relapsed or refractory acute myeloid leukemia: Final results of a randomized phase 2 study Meeting Abstract
| Authors: | Russell, N.; Tallman, M. S.; Goldberg, S.; Perl, A. E.; Marie, J. P.; Martinelli, G.; Larson, R. A.; Schiller, G.; Trone, D.; Gammon, G.; Levis, M.; Cortes, J. E. |
| Abstract Title: | Quizartinib (Ac220) in patients with flt3-Itd(+) relapsed or refractory acute myeloid leukemia: Final results of a randomized phase 2 study |
| Meeting Title: | 19th Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 99 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2014 Jun 12-15 |
| Meeting Location: | Milan, Italy |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2014-06-01 |
| Start Page: | 36 |
| Language: | English |
| ACCESSION: | WOS:000342830900088 |
| PROVIDER: | wos |
| PMCID: | PMC4060398 |
| Notes: | Meeting Abstract: P187 -- 19th Congress of the European-Hematology-Association -- JUN 12-15, 2014 -- Milan, ITALY -- Source: Wos |
MSK Authors
-
649Tallman